Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0C0CE
|
||||
Former ID |
DIB004845
|
||||
Drug Name |
Activated recombinant FVII-albumin fusion protein
|
||||
Synonyms |
CSL-689; Activated recombinant FVII-albumin fusion protein (hemophilia); Activated recombinant FVII-albumin fusion protein (hemophilia), CSL Behring; RVIIa-FP (hemophilia), CSL Behring; Recombinant factor VIIa/human albumin fusion protein (hemophilia), CSL Behring
|
||||
Indication | Hemophilia [ICD9: 286; ICD10:D66-D68] | Phase 2/3 | [1] | ||
Company |
Csl behring
|
||||
Target and Pathway | |||||
Target(s) | Coagulation factor VII | Target Info | Modulator | [2] | |
Serum albumin | Target Info | Modulator | [2] | ||
KEGG Pathway | Complement and coagulation cascades | ||||
PANTHER Pathway | Angiogenesis | ||||
Blood coagulation | |||||
Pathway Interaction Database | FOXA2 and FOXA3 transcription factor networks | ||||
PathWhiz Pathway | Coagulation | ||||
Reactome | BMAL1:CLOCK,NPAS2 activates circadian gene expression | ||||
Extrinsic Pathway of Fibrin Clot Formation | |||||
Gamma-carboxylation of protein precursors | |||||
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus | |||||
Removal of aminoterminal propeptides from gamma-carboxylated proteinsR-HSA-114608:Platelet degranulation | |||||
Recycling of bile acids and salts | |||||
HDL-mediated lipid transport | |||||
Scavenging of heme from plasma | |||||
WikiPathways | Complement and Coagulation Cascades | ||||
PTM: gamma carboxylation, hypusine formation and arylsulfatase activation | |||||
Blood Clotting Cascade | |||||
Formation of Fibrin Clot (Clotting Cascade) | |||||
Circadian Clock | |||||
Folate Metabolism | |||||
Vitamin B12 Metabolism | |||||
Selenium Micronutrient NetworkWP2806:Human Complement System | |||||
Binding and Uptake of Ligands by Scavenger Receptors | |||||
Lipid digestion, mobilization, and transport | |||||
Transport of vitamins, nucleosides, and related molecules | |||||
Bile acid and bile salt metabolism | |||||
Selenium Micronutrient Network | |||||
References | |||||
REF 1 | ClinicalTrials.gov (NCT02484638) Study of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) for On-demand Treatment of Bleeding Episodes in Patients With Hemophilia A or B With Inhibitors. | ||||
REF 2 | ClinicalTrials.gov (NCT01542619) A Safety and Pharmacokinetics Study of a Recombinant Fusion Protein Linking Coagulation Factor VIIa With Albumin (rVIIa-FP) in Healthy Male Volunteers. U.S. National Institutes of Health. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.